Cargando…

Depressive symptoms and health-related quality of life in critical COVID-19 survivors: Preliminary results of 1-year follow-up

INTRODUCTION: A higher risk of mental health consequences in critical COVID-19 patients is expected due to several reasons, including prolonged mechanical ventilation with exposure to high sedation. In this context, post-discharge depression has been reported in previous COVID-19 studies, with a pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins, S., Fontes, L., Ferreira, A.R., Fernandes, J., Vieira, T., Reis, N., Braga, A., Coimbra, I., Paiva, J.A., Fernandes, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563347/
http://dx.doi.org/10.1192/j.eurpsy.2022.793
_version_ 1784808382289412096
author Martins, S.
Fontes, L.
Ferreira, A.R.
Fernandes, J.
Vieira, T.
Reis, N.
Braga, A.
Coimbra, I.
Paiva, J.A.
Fernandes, L.
author_facet Martins, S.
Fontes, L.
Ferreira, A.R.
Fernandes, J.
Vieira, T.
Reis, N.
Braga, A.
Coimbra, I.
Paiva, J.A.
Fernandes, L.
author_sort Martins, S.
collection PubMed
description INTRODUCTION: A higher risk of mental health consequences in critical COVID-19 patients is expected due to several reasons, including prolonged mechanical ventilation with exposure to high sedation. In this context, post-discharge depression has been reported in previous COVID-19 studies, with a profound impact on patients’ health-related quality of life (HRQoL). OBJECTIVES: To identify depressive symptoms in COVID-19 survivors 1-year after hospital discharge and to analyse its association with HRQoL. METHODS: As part of the longitudinal MAPA project, this study enrolled critical COVID-19 patients admitted in the Intensive Care Medicine Department of a University Hospital (March-May 2020). Participants were assessed through telephone by an intensive care nurse and a psychologist, with the Patient Health Questionnaire (PHQ-9) (depressive symptoms), EuroQol five-dimension five-level questionnaire (EQ-5D-5L) and EQ-Visual Analogue Scale (EQ-VAS) (global health status patient record). RESULTS: A sample of 55 survivors (median age=66 years; 69% males) were included, with 20% showing depressive symptoms. Pain/discomfort (67%) and anxiety/depression (67%) were the most EQ-5D-5L domains reported. Survivors scoring for depression had more problems in all HRQoL areas (mobility:91%vs.48%, p=0.015; self-care:64%vs.27%, p=0.035; usual activities:91%vs.50%, p=0.017; pain/discomfort:100%vs.59%, p=0.010; anxiety/depression:100%vs.59%, p=0.010). Moreover, they had a lower EQ-VAS median, corresponding a worse self-perception of health status (50vs.80, p=0.010). CONCLUSIONS: Even after 1-year, a significant proportion of survivors presented depressive symptoms with repercussions in all HRQoL dimensions and association with worse self-perception of global quality of life. Taking this in mind, early screening and treatment of depression in COVID-19 survivors will be crucial, minimizing its impact on quality of life. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9563347
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95633472022-10-17 Depressive symptoms and health-related quality of life in critical COVID-19 survivors: Preliminary results of 1-year follow-up Martins, S. Fontes, L. Ferreira, A.R. Fernandes, J. Vieira, T. Reis, N. Braga, A. Coimbra, I. Paiva, J.A. Fernandes, L. Eur Psychiatry Abstract INTRODUCTION: A higher risk of mental health consequences in critical COVID-19 patients is expected due to several reasons, including prolonged mechanical ventilation with exposure to high sedation. In this context, post-discharge depression has been reported in previous COVID-19 studies, with a profound impact on patients’ health-related quality of life (HRQoL). OBJECTIVES: To identify depressive symptoms in COVID-19 survivors 1-year after hospital discharge and to analyse its association with HRQoL. METHODS: As part of the longitudinal MAPA project, this study enrolled critical COVID-19 patients admitted in the Intensive Care Medicine Department of a University Hospital (March-May 2020). Participants were assessed through telephone by an intensive care nurse and a psychologist, with the Patient Health Questionnaire (PHQ-9) (depressive symptoms), EuroQol five-dimension five-level questionnaire (EQ-5D-5L) and EQ-Visual Analogue Scale (EQ-VAS) (global health status patient record). RESULTS: A sample of 55 survivors (median age=66 years; 69% males) were included, with 20% showing depressive symptoms. Pain/discomfort (67%) and anxiety/depression (67%) were the most EQ-5D-5L domains reported. Survivors scoring for depression had more problems in all HRQoL areas (mobility:91%vs.48%, p=0.015; self-care:64%vs.27%, p=0.035; usual activities:91%vs.50%, p=0.017; pain/discomfort:100%vs.59%, p=0.010; anxiety/depression:100%vs.59%, p=0.010). Moreover, they had a lower EQ-VAS median, corresponding a worse self-perception of health status (50vs.80, p=0.010). CONCLUSIONS: Even after 1-year, a significant proportion of survivors presented depressive symptoms with repercussions in all HRQoL dimensions and association with worse self-perception of global quality of life. Taking this in mind, early screening and treatment of depression in COVID-19 survivors will be crucial, minimizing its impact on quality of life. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9563347/ http://dx.doi.org/10.1192/j.eurpsy.2022.793 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Martins, S.
Fontes, L.
Ferreira, A.R.
Fernandes, J.
Vieira, T.
Reis, N.
Braga, A.
Coimbra, I.
Paiva, J.A.
Fernandes, L.
Depressive symptoms and health-related quality of life in critical COVID-19 survivors: Preliminary results of 1-year follow-up
title Depressive symptoms and health-related quality of life in critical COVID-19 survivors: Preliminary results of 1-year follow-up
title_full Depressive symptoms and health-related quality of life in critical COVID-19 survivors: Preliminary results of 1-year follow-up
title_fullStr Depressive symptoms and health-related quality of life in critical COVID-19 survivors: Preliminary results of 1-year follow-up
title_full_unstemmed Depressive symptoms and health-related quality of life in critical COVID-19 survivors: Preliminary results of 1-year follow-up
title_short Depressive symptoms and health-related quality of life in critical COVID-19 survivors: Preliminary results of 1-year follow-up
title_sort depressive symptoms and health-related quality of life in critical covid-19 survivors: preliminary results of 1-year follow-up
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563347/
http://dx.doi.org/10.1192/j.eurpsy.2022.793
work_keys_str_mv AT martinss depressivesymptomsandhealthrelatedqualityoflifeincriticalcovid19survivorspreliminaryresultsof1yearfollowup
AT fontesl depressivesymptomsandhealthrelatedqualityoflifeincriticalcovid19survivorspreliminaryresultsof1yearfollowup
AT ferreiraar depressivesymptomsandhealthrelatedqualityoflifeincriticalcovid19survivorspreliminaryresultsof1yearfollowup
AT fernandesj depressivesymptomsandhealthrelatedqualityoflifeincriticalcovid19survivorspreliminaryresultsof1yearfollowup
AT vieirat depressivesymptomsandhealthrelatedqualityoflifeincriticalcovid19survivorspreliminaryresultsof1yearfollowup
AT reisn depressivesymptomsandhealthrelatedqualityoflifeincriticalcovid19survivorspreliminaryresultsof1yearfollowup
AT bragaa depressivesymptomsandhealthrelatedqualityoflifeincriticalcovid19survivorspreliminaryresultsof1yearfollowup
AT coimbrai depressivesymptomsandhealthrelatedqualityoflifeincriticalcovid19survivorspreliminaryresultsof1yearfollowup
AT paivaja depressivesymptomsandhealthrelatedqualityoflifeincriticalcovid19survivorspreliminaryresultsof1yearfollowup
AT fernandesl depressivesymptomsandhealthrelatedqualityoflifeincriticalcovid19survivorspreliminaryresultsof1yearfollowup